Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1)

作者
Nathan A. Brooks,Robin I. DeWalt,Serge L. Boulet,ZhaoHai Lu,Lisa M. Kays,Rachel N. Cavitt,Sandra Gomez,John M. Strelow,Paul L. Milligan,Kenneth D. W. Roth,Renato A. Bauer,Stephen Antonysamy,Patric J. Hahn,Zoran Ranković,Denis McCann,Gary Mo,Ramon Velasquez Tiu,Timothy P. Burkholder,Sandaruwan Geeganage,Raymond Gilmour
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:79 (13_Supplement): LB-274 被引量:13
标识
DOI:10.1158/1538-7445.am2019-lb-274
摘要

Abstract Somatic gain-of-function mutations in IDH1 have been identified in multiple tumor types including AML, glioma, cholangiocarcinoma and chondrosarcoma. The neo-enzymatic activity of mutant IDH1 results in accumulation of the oncometabolite 2-hydroxyglutarate (2-HG), leading to a hyper-methylation phenotype, a block in cell differentiation, and tumor growth. Using a structure-based drug design approach, we have developed a highly potent covalent inhibitor of mutant IDH1. LY3410738 modifies a single cysteine (Cys269) in the allosteric binding pocket and rapidly inactivates the enzyme with a KI/Kinact = 84,257 M-1sec-1. The compound selectively inhibits the 2-HG in IDH1 mutant tumor cells without depleting the levels of a-ketoglutarate. Using patient-derived primary AML cells, we demonstrated that LY3410738 was more potent than AG120 in reversing the block in differentiation associated with IDH1 mutant activity. In vivo, LY3410738 displayed prolonged pharmacodynamic activity, depleting 2-HG levels in tumors at low circulating exposures and for an extended time after clearance of compound. Importantly, LY3410738 has the ability to cross the blood-brain barrier and can achieve concentrations in the brain that exceed those needed to engage the target. Consistent with this, LY3410738 effectively inhibits 2HG in orthotopic glioma models. Using patient-derived IDH1 mutant orthotopic AML models, we demonstrated that LY3410738 effectively inhibited 2-HG, induced differentiation, and cleared AML from mice. Collectively, LY3410738 represents the first covalent brain-penetrant mutant IDH1 inhibitor with potential for Best-in-Class activity. Citation Format: Nathan Brooks, Robin DeWalt, Serge Boulet, ZhaoHai Lu, Lisa Kays, Rachel cavitt, Sandra Gomez, John Strelow, Paul Milligan, Kenneth Roth, Renato Bauer, Stephen Antonysamy, Patric Hahn, Zoran Rankovic, Denis McCann, Gary Mo, Ramon Tiu, Timothy Burkholder, Sandaruwan Geeganage, Raymond Gilmour. Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr LB-274.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
毛毛发布了新的文献求助10
3秒前
4秒前
星辰大海的应助被喵喵呜喵喵采纳,获得30
4秒前
熊98完成签到,获得积分10
5秒前
香蕉觅云的应助被xixi采纳,获得10
5秒前
5秒前
THM666发布了新的文献求助10
6秒前
HZH完成签到 ,获得积分10
6秒前
6秒前
guts发布了新的文献求助10
8秒前
打打的应助被PPP采纳,获得10
8秒前
zyx发布了新的文献求助10
9秒前
younger完成签到,获得积分10
9秒前
9秒前
9秒前
HD完成签到,获得积分10
10秒前
李健的应助被爱而不得采纳,获得10
10秒前
整箱发布了新的文献求助10
11秒前
夙夙完成签到,获得积分10
12秒前
科目三的应助被嘿嘿采纳,获得10
12秒前
12秒前
13秒前
13秒前
小刘的应助被车水采纳,获得50
13秒前
夙夙发布了新的文献求助10
15秒前
Grin完成签到,获得积分10
15秒前
小余完成签到,获得积分10
15秒前
小貉发布了新的文献求助10
16秒前
顺利发布了新的文献求助10
17秒前
洁净山柏发布了新的文献求助10
19秒前
充电宝的应助被QLK采纳,获得10
19秒前
21秒前
万能图书馆的应助被顺利采纳,获得10
23秒前
24秒前
哈哈哈完成签到,获得积分10
24秒前
24秒前
钟美蒂的阴灵完成签到,获得积分10
24秒前
jiyi完成签到,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188563
求助须知:如何正确求助?哪些是违规求助? 9576328
关于积分的说明 21846521
捐赠科研通 7786563
什么是DOI,文献DOI怎么找? 3435354
关于科研通互助平台的介绍 2559627
邀请新用户注册赠送积分活动 2482336